SIGMAR1 and lip and oral cavity carcinoma: Overall, our study provides valuable insights into the role of SIGMAR1 in oral cancer pathogenesis and suggests that SIGMAR1-targeted interventions could represent a promising avenue for future clinical trials and therapeutic development in the field of oral cancer treatment.